cotylenin-a and Leukemia--Myeloid--Acute

cotylenin-a has been researched along with Leukemia--Myeloid--Acute* in 2 studies

Reviews

1 review(s) available for cotylenin-a and Leukemia--Myeloid--Acute

ArticleYear
Differentiation of human myeloid leukemia cells by plant redifferentiation-inducing hormones.
    Leukemia & lymphoma, 2002, Volume: 43, Issue:9

    Although differentiation therapy for patients with acute promyelocytic leukemia (APL) using all-trans retinoic acid (ATRA) has now been established, acute myeloid leukemia (AML) patients with other than APL only show a limited clinical response to ATRA. We must consider novel therapeutic drugs against other AML to develop a differentiation therapy for leukemia. Regulators that play an important role in the differentiation and development of plants may also affect the differentiation of human leukemia cells through a common signal transduction system, and might be clinically useful for treating AML. Cytokinins are important purine derivatives that serve as hormones that control many processes in plants. Cytokinins such as kinetin, isopentenyladenine (IPA) and benzyladenine were very effective at inducing nitroblue tetrazolium (NBT) reduction and morphological changes in human myeloid leukemia cells into mature granulocytes. On the other hand, cytokinin ribosides such as kinetin riboside, isopentenyladenosine (IPAR) and benzyladenine riboside were the most potent for inhibiting growth and inducing apoptosis. When the cells were incubated with cytokinin ribosides in the presence of an O2- scavenger, antioxidant or caspase inhibitor, apoptosis was significantly reduced and differentiation was greatly enhanced. These results suggest that both cytokinins and cytokinin ribosides can induce the granulocytic differentiation of HL-60 cells, but cytokinin ribosides also induce apoptosis prior to differentiation. Cotylenin A has been isolated as a plant growth regulator exhibits cytokinin-like activity. Although it has a different structure than cytokinins, it also induces the differentiation of human myeloid leukemia cells. These results suggest that there is an association between the action of plant redifferentiation-inducing hormones and the mechanism of the differentiation of human leukemia cells.

    Topics: Adenine; Antioxidants; Cell Differentiation; Cell Line, Tumor; Cytokinins; Diterpenes; Dose-Response Relationship, Drug; Granulocytes; HL-60 Cells; Hormones; Humans; Inhibitory Concentration 50; Isopentenyladenosine; Leukemia, Myeloid, Acute; Models, Chemical; Nitroblue Tetrazolium; Plant Cells; Plants; Signal Transduction

2002

Other Studies

1 other study(ies) available for cotylenin-a and Leukemia--Myeloid--Acute

ArticleYear
Cotylenin A-induced differentiation is independent of the transforming growth factor-beta signaling system in human myeloid leukemia HL-60 cells.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:4

    Cotylenin A, which has been isolated as a plant growth regulator, potently induces the differentiation of human myeloid leukemia cells. Treatment of HL-60 cells with a combination of transforming growth factor (TGF)-beta and 1alpha, 25-dihydroxyvitamin D(3) (VD3) resulted in increased differentiation compared to separate treatments, but TGF-beta did not affect the cotylenin A-induced differentiation of HL-60 cells. It is possible that the signal transduction pathway used by cotylenin A for inducing the differentiation of leukemia cells is the same as that used by TGF-beta. However, cotylenin A did not affect the expression of TGF superfamily or Smad genes in HL-60 cells. Treatment with neutralizing anti-TGF-beta antibody or an inhibitor of TGF-beta signaling did not inhibit cotylenin A-induced differentiation, although VD3-induced differentiation was significantly suppressed by these treatments. The subcellular distribution of Smad3 was also unaffected by cotylenin A. These results suggest that the cotylenin A-induced differentiation of leukemia cells is independent of the TGF-beta signaling system, although TGF-beta acts as an autocrine mediator of the growth arrest and differentiation of leukemia cells induced by VD3 and other inducers.

    Topics: Cell Differentiation; Cell Line, Tumor; Diterpenes; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Immunohistochemistry; Leukemia, Myeloid, Acute; Models, Biological; RNA, Messenger; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta; U937 Cells

2006